Phospholipid-binding domain of factor VIII is involved in endothelial cell-mediated activation of factor X by factor IXa

被引:17
作者
Brinkman, HJM
Mertens, K
van Mourik, JA
机构
[1] Sanquin Blood Supply Fdn, CLB, Dept Plasma Prot & Blood Coagulat, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
关键词
endothelial cells; factor X activation; factor VIII;
D O I
10.1161/hq0302.105359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apparently quiescent, nonapoptotic endothelial cells mediate the activation of factor X by activated factor IX in the presence of its cofactor, activated factor VIII. In a previous study, we reported that during the activation of factor X, the interaction of the cofactor with the endothelial cell membrane clearly differs from the interaction of the cofactor with artificial lipid membranes. In the present study, we identified the peptide domain of factor VIII involved in the assembly of the enzyme-cofactor complex on the endothelial cell surface. With the use of monoclonal antibodies against different peptide sequences on the factor VIII light chain, it was observed that the lipid-binding region of the C2 domain on the factor VIII light chain mediates the assembly of the factor X-activating complex on the endothelial cell surface. In addition, a synthetic peptide that constitutes region Ala2318-Tyr2332 of the C2 domain and that is known for its ability to inhibit the binding of factor VIII to artificial lipid membranes also showed inhibition of the cofactor activity of factor VIII on endothelial cells. Thus, the carboxy-terminal part of the factor VIII light chain not only contains sites involved in lipid binding but also contains sites involved in complex assembly on the endothelial cell membrane.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 34 条
[1]   MOLECULAR-BASIS OF FACTOR-VIII INHIBITION BY HUMAN-ANTIBODIES - ANTIBODIES THAT BIND TO THE FACTOR-VIII LIGHT CHAIN PREVENT THE INTERACTION OF FACTOR-VIII WITH PHOSPHOLIPID [J].
ARAI, M ;
SCANDELLA, D ;
HOYER, LW .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :1978-1984
[3]   Apoptotic vascular endothelial cells become procoagulant [J].
Bombeli, T ;
Karsan, A ;
Tait, JF ;
Harlan, JM .
BLOOD, 1997, 89 (07) :2429-2442
[4]  
BRIL WS, 2001, THROMB HAEMOSTASIS, V86, pA247
[5]   THE ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-X ON THE SURFACE OF ENDOTHELIAL-CELLS - A COMPARISON WITH VARIOUS VASCULAR CELLS, PLATELETS AND MONOCYTES [J].
BRINKMAN, HJM ;
MERTENS, K ;
HOLTHUIS, J ;
ZWARTHUININK, LA ;
GRIJM, K ;
VANMOURIK, JA .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :332-342
[6]   Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation [J].
Brinkman, HJM ;
Koster, P ;
Mertens, K ;
vanMourik, JA .
BIOCHEMICAL JOURNAL, 1997, 323 :735-740
[7]  
BRINKMAN HJM, 1996, VASCULAR CONTROL HEM, P85
[8]   Identification of the endothelial cell binding site for factor IX [J].
Cheung, WF ;
vandenBorn, J ;
Kuhn, K ;
Kjellen, L ;
Hudson, BG ;
Stafford, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11068-11073
[9]  
CHEUNG WF, 1992, J BIOL CHEM, V267, P20529
[10]  
Cines DB, 1998, BLOOD, V91, P3527